Source: Annual Congress 2007 - Assessment and outcomes in patients with chronic airway obstruction
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Jones, P. Farrar, M. Poland, C. Warburton, P. Calverley, L. Davies (Liverpool, United Kingdom). ²DOSE² index in severe COPD. Eur Respir J 2007; 30: Suppl. 51, 703

Member's Comments

No comment yet.

Related content which might interest you: Karnofsky index as predictor of exacerbations in moderate and severe COPD patients Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Low body mass index in hospitalised patients with chronic obstructive pulmonary disease (COPD): is related to low lung function and increased mortality Source: Eur Respir J 2006; 28: Suppl. 50, 66s Year: 2006 BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007 Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 The body-mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index in Filipino patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 57s Year: 2005 Significance of quantitative radiological phenotypes of COPD on BODE index Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Body mass index, central obesity, and severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD mechanisms Year: 2011 The derivation of a new index of severity for COPD patients, the DOSE index: MRC dyspnea scale, airflow obstruction, smoking status and exacerbations Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation Year: 2007 Static hyperinflation and respiratory disability were associated with frequent-exacerbation phenotype in patients with severe COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Severity assessment in acute exacerbations of COPD Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005 Sex differences in mortality in patients with COPD Source: Eur Respir J 2009; 33: 528-535 Year: 2009 The modified BODE index: validation with mortality in COPD Source: Eur Respir J 2008; 32: 1269-1274 Year: 2008 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 A new multidimensional model for predicting mortality in COPD: body mass index and FEV1 quotient/MRC dyspnoea score (SID) Source: Annual Congress 2006 - COPD – the challenges for primary care Year: 2006 Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 Fatigue in COPD: association with functional status and hospitalisations Source: Eur Respir J 2013; 41: 565-570 Year: 2013 Assessment of severe COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Additional value of spirometry in risk assessment of acute respiratory disease in winter among patients with mild to moderate asthma or COPD Source: Eur Respir J 2002; 20: Suppl. 38, 473s Year: 2002 Fat-free mass depletion and functional exercise capacity in COPD patients Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation Year: 2007 Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008